New Key Statistics Module, Z-Score and F-Score
AMEX:PLX Key Ratios
| Market Cap $ M | 84.01 |
| Enterprise Value $ M | 67.92 |
| P/E(ttm) | 57.50 |
| PE Ratio without NRI | 57.50 |
| Forward PE Ratio | -- |
| Price/Book | 2.50 |
| Price/Sales | 1.36 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 65.00 |
| EPS (TTM) $ | 0.02 |
| Beneish M-Score | -1.28 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 5.78 |
| EV-to-EBITDA | 5.25 |
| PEG | -- |
| Shares Outstanding M | 73.05 |
| Net Margin (%) | 12.69 |
| Operating Margin % | 15.97 |
| Pre-tax Margin (%) | 13.08 |
| Quick Ratio | 1.12 |
| Current Ratio | 1.54 |
| ROA % (ttm) | 10.86 |
| ROE % (ttm) | 41.07 |
| ROIC % (ttm) | 33.60 |
| Dividend Yield % | -- |
| Altman Z-Score | -3.73 |
PLX Number of Guru Trades
PLX Volume of Guru Trades
Gurus Latest Trades with AMEX:PLX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:PLX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Protalix BioTherapeutics Inc Insider Transactions
No Available Data
News about AMEX:PLX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers